Clinical and virological study on Bell's palsy
Clinical and virological study on Bell's palsy
批准号:
14207067
负责人:
AOYAGI Masaru
金额:
$27.29万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004
中文摘要
点击翻译按钮获取中文摘要
英文摘要
1.Bell's palsy treatment with prednisolone and valaciclovirWe performed a multi-center prospective, randomized study between Sep.2002 and Dec.2004. The subjects, who were within one week of the onset of Bell's palsy and who had not yet been treated, were randomly allocated to one of two groups ; one with oral administration of prednisolone (60 mg/day tapering 10 days) alone and the other in a combined treatment group with an anti-viral agent (valaciclovir, 1000 mg/day, 5 days). The final results of these therapeutic regimens were compared. Of a total 143 patients, 63 received prednisolone alone and 80 received prednisolone plus valaciclovir. In the group treated with prednisolone alone, 54 of 63 patients were judged to have recovered, while for the group treated with the valaciclovir combination, 72 of the 80 patients were judged to have been cured. The recovery rates for the prednisolone-treated and valaciclovir combination groups were 85.7 and 90.0%, respectively. Among the patients … More with complete paralysis (a palsy score lower than 8 on the 40-point Japanese grading system), the recovery rates were 77.8% and 79.3%, respectively. The above-mentioned results show that the recovery rates were the same in both treatment groups.2.A virological evaluation of patients with Bell's palsyTo detect reactivation of herpes simplex virus type-1 (HSV-1) and varicella zoster virus (VZV) in patients with Bell's palsy, we performed virological assay. Materials and Methods : 106 patients who had given a diagnosis of clinical Bell's palsy were enrolled in this study. Patients with Ramsay Hunt syndrome were excluded. We examined antibody titers against HSV and VZV by highly sensitive enzyme immunoassay, viral DNA detection in saliva by real-time PCR and virus isolation by cell culture. Results : Reactivation of HSV-1 was detected in 12 patients (11.3%). Reactivation of VZV was detected in 16 patients (15.1%). Furthermore, reactivation of both viruses was detected in 5 patients (4.7%).Conclusions : It is difficult to detect reactivation of these viruses using only serological assay and virus isolation at the onset of Bell's palsy. However, pair serological study and real-time PCR were effective in detecting these viral reactivations. Although the cause of Bell's palsy is controversial, reactivation of HSV-1 and VZV may be the major cause of Bell's palsy. Our results suggest that reactivation of these viruses is induced after the onset of Bell's palsy in some patients. Less
期刊论文(17)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
顔面神経麻痺の予後予測はどこまで可能か
在多大程度上可以预测面神经麻痹的预后?
DOI:
--
发表时间:
2005
期刊:
日本耳鼻咽喉科学会報 108
影响因子:
--
作者:
[近間泰一郎, 近本信彦, 川本晃司, 川本晃司, Youichiro Fujitsu., Ji-Long Hao., Ken Fukuda, Ken Fukuda, Ryoji Yanai, Ryoji Yanai, Koji Kawamoto, Ken Fukuda, Tai-ichiro Chikama, 青柳 優]
通讯作者:
青柳 優
ベル麻痺に対するステロイド単独治療とバラシクロビル併用の効果
类固醇单药治疗和伐昔洛韦联合治疗贝尔氏麻痹的效果
DOI:
--
发表时间:
2004
期刊:
Facial Nerve Research Japan 24
影响因子:
--
作者:
[甲州 秀浩, 他]
通讯作者:
他
顔面神経麻痺の疫学と治療
面瘫的流行病学和治疗
DOI:
--
发表时间:
2004
期刊:
Herpes Management 8
影响因子:
--
作者:
[村上景子, 北迫勇一, 山貫幹人, 野村聡, 中西剛, 田上順次, 村上信五]
通讯作者:
村上信五
顔面神経麻痺治療法に関する全国アンケート調査
全国面神经麻痹治疗方法问卷调查
DOI:
--
发表时间:
2004
期刊:
Facial Nerve Research Japan 24
影响因子:
--
作者:
[村上 信五, 他]
通讯作者:
他
Bell麻痺患者における早期病因診断(ウイルス学的検討)
贝尔麻痹患者的早期病因诊断(病毒学研究)
DOI:
--
发表时间:
2004
期刊:
Facial N Res Jpn 24
影响因子:
--
作者:
[川口和浩, 他]
通讯作者:
他
共 15 条
Creation of and Application of Metal-Organic Nanotube Hybrid Catalysts for Low Environmental Impact Chemical Process
-
批准号:23560937
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2011
-
负责人:AOYAGI Masaru
-
依托单位:
STRESS-ACTIVATED SIGNALING PATHWAY AND GENE ANALYSIS IN VASCULAR CELLS DERIVED FROM PATIENTS WITH MOYAMOYA DISEASE
-
批准号:15591510
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2003
-
负责人:AOYAGI Masaru
-
依托单位:
STRESS-ACTIVATED SIGNALING IN VASCULAR SMOOTH MUSCLE CELLS DERIVED FROM PATIENTS WITH MOYAMOYA DISEASE
-
批准号:13671423
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2001
-
负责人:AOYAGI Masaru
-
依托单位:
DISTINCT RESPONSE TO INFLAMMATORY CYTOKINES IN ARTERIAL
-
批准号:10671285
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:1998
-
负责人:AOYAGI Masaru
-
依托单位:
Development of Automatic Objective Audiometry Device
-
批准号:09671732
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.98万
-
财政年份:1997
-
负责人:AOYAGI Masaru
-
依托单位:
Experimental and clinical study on the steady-state response elicited by sinusoidally amplitude-modulated tones.
-
批准号:07671840
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1995
-
负责人:AOYAGI Masaru
-
依托单位:
ESTABLISHMENT AND CHARACTERIZATION OF CULTURED VASCULAR ENDOTHELIAL CELLS DERIVED FROM PATIENTS WITH MOYAMOYA DISEASE
-
批准号:06671378
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1994
-
负责人:AOYAGI Masaru
-
依托单位:
FUNCTIONAL ALTERATIONS IN VASCULAR CELLS OF PATIENTS WITH MOYAMOYA DISEASE.
-
批准号:04454355
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$0.96万
-
财政年份:1992
-
负责人:AOYAGI Masaru
-
依托单位:
A Cinical and a fundamental study of the efficacy and the safety of Transcraniol Magnetic Stimmulation on facial movement disorders.
-
批准号:04454428
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.42万
-
财政年份:1992
-
负责人:AOYAGI Masaru
-
依托单位:
国内基金
海外基金
登录
查看更多内容
脑膜中性粒细胞作为“非常规APC”介导低亲和力T细胞参与HSV-1感染后免疫的机制研究
-
批准号:2026JJ50585
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘鼎
-
依托单位:
STING对HSV-1引起的急性视网膜坏死的
抑制作用研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:龚莉莉
-
依托单位:
新型天然间苯三酚二聚体的仿生合成及其抗HSV-1活性构效关系和作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:30.0万元
-
批准年份:2024
-
负责人:胡利军
-
依托单位:
HSV-1通过YTHDF2介导的m6A甲基化修饰调控RIG-I/MAVS信号通路在其免疫逃逸中的作用和机制研究
-
批准号:82302515
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:黄会超
-
依托单位:
在HSV-1潜伏感染中LAT通过激活NLRP3炎症小体调控tau蛋白磷酸化诱发AD的机制研究
-
批准号:82360393
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:程继帅
-
依托单位:
ACOD1/衣康酸通过促进HSP90β介导的cGAS-STING-IFN通路抑制HSV-1嗜神经感染的作用与机制研究
-
批准号:82372244
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2023
-
负责人:郑楷
-
依托单位:
开发响应HSV-1的智能病毒传感器及其应用研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:王义丹
-
依托单位:
HSV-1早期蛋白hUDG负调控RIG-I样受体通路介导干扰素产生的作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:蔡铭升
-
依托单位:
MSC携带HSV-1膜融合蛋白靶向杀伤肿瘤的作用与机制研究
-
批准号:82272813
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:徐波
-
依托单位:
炎症激活型溶瘤HSV-1介导CIITA基因表达促进肿瘤免疫治疗的模型评价和机制研究
-
批准号:82260486
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:黄新伟
-
依托单位: